ArticleGut2021

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.

Marta B Afonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.